搜索临床试验以:SHR-1210 联合曲妥珠单抗、奥沙利铂和卡培他滨
总计187个结果
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu Hengrui Pharmaceutical Co., Ltd.未知
-
Fundación para el Progreso de la Oncología en Cantabria完全的
-
The Netherlands Cancer Institute未知
-
Baptist Health South FloridaSeagen Inc.招聘中
-
Jiangsu HengRui Medicine Co., Ltd.完全的
-
Peking Union Medical College HospitalPeking University People's Hospital; Beijing Friendship Hospital; Cancer Institute and Hospital... 和其他合作者未知直肠癌, 腺癌 | 新辅助放化疗
-
Peking University Cancer Hospital & Institute尚未招聘
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's Hospital主动,不招人
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.未知
-
NSABP Foundation IncAmgen撤销
-
Jiangsu HengRui Medicine Co., Ltd.招聘中先前接受过曲妥珠单抗和紫杉烷治疗的 HER2 阳性、不可切除和/或转移性乳腺癌受试者中国
-
Peking University People's HospitalPeking University; Sanofi未知
-
Shanghai Pulmonary Hospital, Shanghai, ChinaJiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences完全的
-
Fudan University主动,不招人
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Hoosier Cancer Research NetworkSanofi; Hoffmann-La Roche; Walther Cancer Institute终止
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche完全的